At present, it is widely admitted not proposing immediate mammary reconstruction when an adjuvant radiotherapy is indicated because of the significant change of the cosmetic result (profit) and it whatever is the technique of reconstruction adopted. This is true all the more as it is about a reconstruction by prosthesis because of the prothetic died risk of hull(shell). Teams proposed immediate mammary reconstructions to expanding (carrier) patients of carcinoma infiltrating, sometimes locally moved forward. For these patients, was not brought back(reported) by increase of the risk of local or remote relapse. Two studies estimated afterward the feasibility of the mastectomy with immediate mammary reconstruction at the close of the chemotherapy and of the radiotherapy. The rate of morbidity is judged as acceptable. The rate of local second offense(recurrence) was similar to the patients benefiting from the classic therapeutic plan. During an other study ( M-RIC), it was shown that the inversion of therapeutic sequence is possible and that by prescribing the chemotherapy and the radiotherapy before immediate mammary reconstruction, the morbidity is acceptable. It is acquired that the chemotherapy néoadjuvant is equivalent to the post-operative chemotherapy as regards the global survival. On the other hand, the rate of histological answer, according to subgroups, is very different. This rate can vary of 9 % for tumors RH +, negative Her2 in 45 % for tumors RH-, Her2 over expression. There are 33 % for the RH +, Her2 + and of 35 % for triple-negative. The purpose of the investigators study is to estimate the rate of histological response during the inversion of therapeutic sequence to make sure of the oncologic safety(security), in particular by molecular subgroups, considering the heterogeneousness of the results(profits) after chemotherapy néoadjuvant only. Sataloff and Chevallier Classifications is the references and will be used here, but the investigators can also use Symmans classification in addition. The rate of local and metastatic second offenses(recurrences) will also be estimated.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
101
Chemotherapy administration then radiotherapy and then surgery : mastectomy and immediate mammary reconstruction.
Chemotherapy treatment
Radiation therapy
Institut Paoli-Calmettes
Marseille, Bouches-du-Rhône, France
Institut Paul Papin
Angers, France
Polyclinique Urbain V
Avignon, France
Capio-Clinique Belharra
Bayonne, France
Institut Bergonie
Bordeaux, France
Centre Jean Perrin
Clermont-Ferrand, France
Institut Oscar Lambret
Lille, France
Clinique Clementville
Montpellier, France
Icm - Institut Regional Du Cancer de Montpellier
Montpellier, France
Institut Jean Godinot
Reims, France
Rate of histological response of an infiltrating tumor within various molecular subgroups
Tumor Histological response (group RH+ Her2+, group RH+ Her2-, group RH- Her2+, and group RH- Her2-)
Time frame: from surgery up to 1 month
Rate of ganglionar response on the axillary lymph nodes after chemotherapy and radiotherapy néoadjuvant
Number of lymph nodes collected and number of positive lymph nodes
Time frame: from surgery up to 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.